What Is THCh? Effects, Legality and the 10x Myth

> Nine Realms doesn't sell THCh. This article is purely informational.

Full name: Tetrahydrocannabihexol. Chemical formula C₂₂H₃₂O₂. Structurally, it's a THC homologue with a hexyl side chain: six carbons where regular THC has five. That single extra carbon is the whole story chemically, and the source of every claim about THCh's potency. The chemistry isn't new: Roger Adams synthesised the parahexyl isomer in 1942 (JACS). The plant isolation is much newer. Linciano and colleagues isolated THCh from cannabis variety FM2 in 2020 (Scientific Reports). So: an old chemistry, a recent botanical finding, a brand-new product class.

Here's where THCh sits among its more familiar relatives.

Half the THCh row is "unknown." And that's not us hedging. That's the actual state of the published evidence that cannabis users are being fed all over Europe.

This is the single most important paragraph in the article. The claim that THCh binds the CB1 receptor "ten times more strongly than THC" appears on almost every German page that sells the compound. The claim has no THCh primary source. The number is carried over from a different, well-published study about a different cannabinoid.

Here's what actually happened. Citti and colleagues published a paper in Scientific Reports in 2019 measuring the CB1 binding affinity of THCP (the P is for phorol, a seven-carbon side chain). They found THCP's Ki at around 1.2 nM versus THC's roughly 40 nM, giving THCP about thirty-three times THC's binding affinity. Roughly two years later, when commercial interest moved on to THCh (a different homologue with a six-carbon chain), marketing copy lifted "ten times THC" (possibly halved from THCP's number to seem less alarming, possibly invented outright) and pasted it onto THCh. Linciano's 2020 paper, which actually isolated THCh, did not measure THCh's CB1 binding. It measured CBDH's antinociceptive effect in mice. Wikipedia's THCh page lists no Ki at all.

So when a vendor tells you THCh is ten times stronger than THC: that number has nothing behind it. The compound it actually applies to (THCP) has different chemistry, different structure, and different available data.

What people commonly report about THCh effects, hedged hard because there's no controlled human research:

• Mild buzz at low doses: anecdotal, varies widely between users.
• Heavier at higher doses: also anecdotal, also varies.
• Onset and duration: unconfirmed; reports cluster around THC-like timelines.
• Side effects: probably similar to other THC-class cannabinoids (dry mouth, dry eyes, raised heart rate, possible anxiety at higher doses), but no published study confirms this for THCh specifically.

So is THCh psychoactive? Probably, qualitatively THC-like. Stronger than THC? Nobody can honestly say. The honest position: less data exists on THCh than on almost any other cannabinoid you'll see on a shop shelf.

Stand: June 2026. As of writing, THCh is not specifically named on the Neue-psychoaktive-Stoffe-Gesetz (NpSG) anchor list, and KCanG (the cannabis-specific law) does not govern it. KCanG applies to Cannabis sativa plant material, not isolated semi-synthetic homologues. That makes THCh sit in the same uncomfortable grey area that HHC briefly occupied before restrictions tightened.

THCh is widely considered a candidate for inclusion in the 7. NpSG-Änderungsverordnung expected around autumn 2026, alongside THCB and THCJD. It also probably falls under the synthetic-cannabimimetic group anchor in NpSG by virtue of being derived from CBD/CBG precursors, which would mean a legal challenge could already succeed even before a specific naming.

In practical terms: technically available now, legally fragile, and the situation can change with a single new ordinance. Check the current legal position before you buy, sell, or carry it. The status that was true last month may not be true this one.

The honest answer is the unsatisfying one: nobody knows for certain, so assume it could show up. No published study has measured whether THCh or its breakdown products cross-react with the standard THC-COOH immunoassay used in workplace tests, traffic stops under §24a StVG, or pre-employment screening. The metabolic pathway is likely analogous to THC's, which means a positive is plausible even if the test isn't specifically looking for THCh. The general factors that move detection in any direction:

• Test type: urine, blood, and saliva have different windows and sensitivities.
• Frequency of use: regular use lingers far longer than a one-off.
• Your metabolism: body fat, hydration, liver function all shift the timeline.
• Whether the lab even looks for THCh: most labs run a broad cannabinoid screen, not a single-compound assay.

If a clean result matters to you (driving, work, anything official), assume THCh might trigger a positive and don't risk it. The safer bet is also the easier one.

We don't sell THCh. We're writing about it because customers ask, and because the pages currently explaining the compound are run by shops with skin in the game. That's a structural problem for honest information. The pattern across these new cannabinoids (CBG9, CB9, THCh) is the same one: thin published data, thick marketing, and a steady commercial pressure to turn an absence of evidence into a confident sales pitch. We'd rather do the opposite. For the cannabinoid family that THCh sits next to, our CBG9 explainer and our CB9 legality and safety guide take the same calm, hedged stance.